Labcorp and Quest Diagnostics both plan to offer the test, which secured CE mark certification earlier this year.

Adults showing signs of memory loss and cognitive decline can now be screened for Alzheimer’s disease with a simple blood draw instead of a spinal tap or an expensive brain scan. The Food and Drug ...

In a move that could help drastically slow the advancement of Alzheimer's disease (AD), the US Food and Drug Administration ...

The FDA has cleared the new single-biomarker pTau217 blood test to help doctors detect signs of Alzheimer's. Medical News ...

The FDA has cleared the first blood test to diagnose Alzheimer's disease. Bowery Image Group Inc./Stocksy Like all diseases, the sooner Alzheimer's disease is diagnosed, the better the outcome. This ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to the first blood test to aid in diagnosing Alzheimer’s disease (AD). The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio, ...

The Elecsys pTau217 test can help doctors assess amyloid pathology in people 55 and older showing signs of cognitive decline ...

A blood sample analysis can detect markers of this disease at early stages, providing a cheaper and less invasive option for diagnosis. In clinical trials, the Lumipulse blood test was highly accurate ...

The FDA cleared the first and only single-biomarker blood test for assessing amyloid pathology to rule in or rule out Alzheimer disease in adults aged 55 and older. 1 ...

We're now closer to being able to diagnose the most common form of dementia with a simple test. The Food and Drug Administration on May 16 said it cleared the first blood test for Alzheimer's disease.

The new test promises to be “minimally invasive” and can help doctors identify symptoms of Alzheimer’s disease earlier.